Feasibility of Delivering a Quitline Based Smoking Cessation Intervention in Cancer Patients (NCT01434342) | Clinical Trial Compass
CompletedEarly Phase 1
Feasibility of Delivering a Quitline Based Smoking Cessation Intervention in Cancer Patients
United States146 participantsStarted 2011-10-01
Plain-language summary
RATIONALE: Continued smoking after a cancer diagnosis has important health consequences beyond the risks associated with smoking in the general population. Smoking reduces the efficacy of cancer treatments including surgery, radiation and chemotherapy. Despite the negative consequences, it is estimated that between 15-75% of patients with cancer continue to smoke after their cancer diagnosis. Lung, breast, prostate, colorectal, bladder, head \& neck, and cervical cancer patients were chosen because there is evidence of potential clinical benefit associated with quitting smoking in all of these populations and they represent a mix of both smoking and non-smoking related cancers.
Who can participate
Age range18 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion criteria
✓. AJCC Stages 0, I, II, \& III lung, breast, prostate, colorectal, bladder, head \& neck, and cervical cancers (all histologies).
✓. Reports smoking any amount in the last 7 days.
✓. Scheduled to receive or currently receiving surgery, radiation or chemotherapy OR have received one or more of the following in the last 6 months surgery, last radiation treatment or last chemotherapy treatment.
✓. 18 years of age or older
✓. KPS of 70-100
✓. Ability to understand and the willingness to sign a written informed consent document.
✓. Willing to consider quitting smoking
Exclusion criteria
✕. Unstable cardiac disease - defined as congestive heart failure, unstable angina, serious arrhythmias, or Myocardial Infarction in the past month.
✕. Current use or planned use of varenicline (Chantix), Zyban, Buproprion or any other nicotinic receptor agonist (Patients that discontinue use of these type drugs within 7 days are eligible.)
What they're measuring
1
Feasibility of a Smoking Cessation Intervention Among Cancer Patients
✕. Current probable alcohol abuse as defined by more than 5 drinks per day for men and 4 drinks per day for women and a Alcohol Use Disorders Identification Test (AUDIT) score \> 8.
✕. Use of illegal drugs or use of prescription medications for non-medical reasons in the past month.
✕. Current use of chewing, dipping and pipe tobacco, or cigars.
✕. Patient does not have regular access to a telephone to receive Quitline calls lasting 15-30 minutes.
✕. History of allergic reactions attributed to compounds of similar chemical or biologic composition to nicotine replacement therapy.